皇家华人

header-logo
GettyImages-609179959-hero
headshot

James D. Rizzo, MD

Professor

view physician profile

Locations

  • Froedtert Hospital
  • Cancer Center - Froedtert Hospital

Specialties

  • Medical Oncology

Languages

  • English

Education

  • MD - Doctor of Medicine

Biography

Dr. Rizzo is an attending physician in the MCW adult HCT unit, with clinical interests in hematologic malignancies and late effects of HCT. He completed a fellowship in hematology/oncology and a Robert Wood Johnson fellowship in epidemiology and cost-effectiveness research at Johns Hopkins University and holds an MS degree in epidemiology from MCW. He has taken a leadership role in several American Society of Hematology initiatives and participated in several committees. He is also an active member of the American Society for Blood and Marrow Transplant Quality Outcomes, Standardization of Outcomes, and Evidence Based Review Steering Committees.

Research Interests

Dr. J. Douglas Rizzo has ten years of experience with the Center for International Blood and Marrow Transplant Research (CIBMTR) at the 皇家华人, an internationally recognized research organization. In his role as CIBMTR Senior Scientific Director and CIBMTR program leader for observational research, he has had primary responsibility for data operations and management staff oversight. He is responsible for implementation of the Stem Cell Therapeutics Outcomes Database at the CIBMTR, part of the national C.W. Bill Young Cell Transplantation Program. His research interests include late effects and quality of life after Hematopoietic Cell Transplantation (HCT), access to HCT across gender and ethnic/racial groups and other health policy issues.

Publications

  • (Dandoy CE, Adams J, Artz A, Bredeson C, Dahi PB, Dodd T, Jaglowski S, Lehmann L, LeMaistre CF, Mian A, Neal A, Page K, Rizzo JD, Rotz S, Sorror M, Steinberg A, Viswabandya A, Howard DS, Committee on Quality Outcomes of the American Society of Transplant and Cellular Therapy.) Transplant Cell Ther. 2024 Oct;30(10):942-954 PMID: 39067790 SCOPUS ID: 2-s2.0-85200735546 07/28/2024

  • (Schonfeld SJ, Valcarcel B, Meyer CL, Shaw BE, Phelan R, Rizzo JD, Brunson A, Cooley JJP, Abrahão R, Wun T, Gadalla SM, Engels E, Albert PS, Yusuf R, Spellman SR, Curtis RE, Auletta JJ, Muffly L, Keegan THM, Morton LM.) Blood Adv. 2024 Aug 13;8(15):4102-4112 PMID: 38865710 PMCID: PMC11342185 SCOPUS ID: 2-s2.0-85201458048 06/12/2024

  • (Turcotte LM, Wang T, Beyer KM, Cole SW, Spellman SR, Allbee-Johnson M, Williams E, Zhou Y, Verneris MR, Rizzo JD, Knight JM.) Proc Natl Acad Sci U S A. 2024 Jul 23;121(30):e2404108121 PMID: 39008669 PMCID: PMC11287259 SCOPUS ID: 2-s2.0-85199015473 07/15/2024

  • (Valcarcel B, Schonfeld SJ, Meyer CL, Brunson A, Cooley JJP, Abrahão R, Wun T, Auletta JJ, Gadalla SM, Engels E, Albert PS, Spellman SR, Rizzo JD, Shaw BE, Muffly L, Keegan THM, Morton LM.) Transplant Cell Ther. 2024 Feb;30(2):239.e1-239.e11 PMID: 37981238 PMCID: PMC10872486 SCOPUS ID: 2-s2.0-85180597524 11/20/2023

  • (Cho C, Devlin S, Maloy M, Horowitz MM, Logan B, Rizzo JD, Giralt SA, Perales MA.) Bone Marrow Transplant. 2023 Oct;58(10):1089-1095 PMID: 37422574 PMCID: PMC10592419 SCOPUS ID: 2-s2.0-85164194423 07/09/2023

  • (Auletta JJ, Kou J, Chen M, Bolon YT, Broglie L, Bupp C, Christianson D, Cusatis RN, Devine SM, Eapen M, Hamadani M, Hengen M, Lee SJ, Moskop A, Page KM, Pasquini MC, Perez WS, Phelan R, Riches ML, Rizzo JD, Saber W, Spellman SR, Stefanski HE, Steinert P, Tuschl E, Yusuf R, Zhang MJ, Shaw BE.) Transplant Cell Ther. 2023 Jun;29(6):346.e1-346.e10 PMID: 36924931 PMCID: PMC10239334 SCOPUS ID: 2-s2.0-85153327578 03/17/2023

  • (Saccardi R, Putter H, Eikema DJ, Busto MP, McGrath E, Middelkoop B, Adams G, Atlija M, Ayuk FA, Baldomero H, Beguin Y, de la Cámara R, Cedillo Á, Balari AMS, Chabannon C, Corbacioglu S, Dolstra H, Duarte RF, Dulery R, Greco R, Gusi A, Hamad N, Kenyon M, Kröger N, Labopin M, Lee J, Ljungman P, Manson L, Mensil F, Milpied N, Mohty M, Oldani E, Orchard K, Passweg J, Pearce R, de Latour RP, Poirel HA, Rintala T, Rizzo JD, Ruggeri A, Sanchez-Martinez C, Sanchez-Guijo F, Sánchez-Ortega I, Trnková M, Ferreiras DV, Wilcox L, de Wreede LC, Snowden JA.) Bone Marrow Transplant. 2023 Jun;58(6):659-666 PMID: 36894635 PMCID: PMC9995719 SCOPUS ID: 2-s2.0-85149466633 03/10/2023

  • (Chhabra S, Visotcky A, Pasquini MC, Zhu F, Tang X, Zhang MJ, Thompson R, Abedin S, D'Souza A, Dhakal B, Drobyski WR, Fenske TS, Jerkins JH, Rizzo JD, Runaas L, Saber W, Shah NN, Shaw BE, Horowitz MM, Hari PN, Hamadani M.) Transplant Cell Ther. 2022 Oct;28(10):717 PMID: 36202527 SCOPUS ID: 2-s2.0-85101258094 10/07/2022

  • (D'Souza A, Fretham C, Lee SJ, Arora M, Brunner J, Chhabra S, Devine S, Eapen M, Hamadani M, Hari P, Pasquini MC, Perez W, Phelan RA, Riches ML, Rizzo JD, Saber W, Shaw BE, Spellman SR, Steinert P, Weisdorf DJ, Horowitz MM.) Transplant Cell Ther. 2022 Oct;28(10):715-716 PMID: 36202526 SCOPUS ID: 2-s2.0-85108559179 10/07/2022

  • (Cusatis R, Flynn KE, Vasu S, Pidala J, Muffly L, Uberti J, Tamari R, Mattila D, Mussetter A, Bruzauskas R, Chen M, Leckrone E, Myers J, Mau LW, Rizzo JD, Saber W, Horowitz M, Lee SJ, Burns LJ, Shaw B.) Transplant Cell Ther. 2022 Feb;28(2):112.e1-112.e9 PMID: 34757219 PMCID: PMC8915447 SCOPUS ID: 2-s2.0-85121127060 11/11/2021

  • (Chhabra S, Visotcky A, Pasquini MC, Zhu F, Tang X, Zhang MJ, Thompson R, Abedin S, D'Souza A, Dhakal B, Drobyski WR, Fenske TS, Jerkins JH, Rizzo JD, Runaas L, Saber W, Shah NN, Shaw BE, Horowitz MM, Hari PN, Hamadani M.) Transplantation and Cellular Therapy. October 2022;28(10):717 SCOPUS ID: 2-s2.0-85101258094 10/01/2022

  • (D'Souza A, Fretham C, Lee SJ, Arora M, Brunner J, Chhabra S, Devine S, Eapen M, Hamadani M, Hari P, Pasquini MC, Perez W, Phelan RA, Riches ML, Rizzo JD, Saber W, Shaw BE, Spellman SR, Steinert P, Weisdorf DJ, Horowitz MM.) Transplantation and Cellular Therapy. October 2022;28(10):715-716 SCOPUS ID: 2-s2.0-85108559179 10/01/2022

Publications of from the

© 2024 皇家华人.  All rights reserved.  | Terms and Privacy 

Non-Discrimination Statement
The 皇家华人 (MCW) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, or military status. Employees, students, applicants or other members of the MCW community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic. MCW’s policy as well as federal and state laws and regulations prohibit unlawful discrimination and harassment.